Literature DB >> 23994362

The chitinase-like protein YKL-40 increases mucin5AC production in human bronchial epithelial cells.

Chunyi Liu1, Qi Li, Xiangdong Zhou, Victor P Kolosov, Juliy M Perelman.   

Abstract

Mucus overproduction is an important feature in patients with chronic inflammatory airway diseases. However, the regulatory mechanisms that mediate excessive mucin production remain elusive. Recently, the level of YKL-40, a chitinase-like protein, has been found to be significantly increased in chronic inflammatory airway diseases and has been shown to be associated with the severity of these diseases. In this study, we sought to explore the effect of YKL-40 on mucin5AC (MUC5AC) production in chronic inflammatory airway diseases and the potential signaling pathways involved in this process. We found that elevated YKL-40 levels increased the mRNA and protein expression of MUC5AC in a dose- and time-dependent manner, in association with the phosphorylation of extracellular signal-regulated kinase (ERK) and nuclear factor κB (NF-κB), reflecting their activation. These responses were significantly suppressed by the knockdown of protease-activating receptor 2 (PAR2) with specific small interfering RNA or the inhibitors of ERK and NF-κB. YKL-40-induced MUC5AC overproduction was also effectively attenuated by the inhibitor of focal adhesion kinase (FAK). Taken together, these results imply that YKL-40 can stimulate excessive MUC5AC production through PAR2- and FAK-mediated mechanisms.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  Extracellular signal-regulated kinase; Focal adhesion kinase; Mucin5AC; Nuclear factor κB; Protease-activating receptor 2; YKL-40

Mesh:

Substances:

Year:  2013        PMID: 23994362     DOI: 10.1016/j.yexcr.2013.08.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Chitinase 3-Like 1 Promotes Candida albicans Killing and Preserves Corneal Structure and Function by Controlling Host Antifungal Responses.

Authors:  Nan Gao; Fu-Shin X Yu
Journal:  Infect Immun       Date:  2015-08-03       Impact factor: 3.441

2.  Preliminary Study on Gene Expression of Chitinase-Like Cytokines in Human Airway Epithelial Cell Under Chitin and Chitosan Microparticles Treatment.

Authors:  Masumeh Alimohammadi; Farshid Yeganeh; Mostafa Haji Molla Hoseini
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

3.  Proteomic and transcriptomic analysis of lung tissue in OVA-challenged mice.

Authors:  Yongjin Lee; Yun-Ho Hwang; Kwang-Jin Kim; Ae-Kyung Park; Man-Jeong Paik; Seong Hwan Kim; Su Ui Lee; Sung-Tae Yee; Young-Jin Son
Journal:  Arch Pharm Res       Date:  2017-10-30       Impact factor: 4.946

4.  The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases.

Authors:  Ines Mack; Andreas Hector; Marlene Ballbach; Julius Kohlhäufl; Katharina J Fuchs; Alexander Weber; Marcus A Mall; Dominik Hartl
Journal:  Mol Cell Pediatr       Date:  2015-02-27

Review 5.  New perspectives on the regulation of type II inflammation in asthma.

Authors:  Mireya Becerra-Díaz; Marsha Wills-Karp; Nicola M Heller
Journal:  F1000Res       Date:  2017-06-28

Review 6.  Chitinase-3 like-protein-1 function and its role in diseases.

Authors:  Ting Zhao; Zhongping Su; Yingchang Li; Xiaoren Zhang; Qiang You
Journal:  Signal Transduct Target Ther       Date:  2020-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.